Baseline and on-treatment characteristics of the genotype 2/3 patients in the complete DITTO study, the genotype 2/3 patients available for the present study, and the genotype 2/3 patients available for the T cell study.

Median (range) or individuals (percent). Statistics using aMann-Whitney U test and bχ2 test.cP-value for all genotype 2/3 patients in the study compared with the patients available for sCD26 analysis.dP-value for all genotype 2/3 patients available for analysis of sCD26 compared with HLA-A2 or HLA-A3 patients available for the tetramer study. n.a. = not applicable.